Porphyria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria
Conditions:   Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria Interventions:   Biological: Hemin for injection;   Other: Placebo Sponsor:   The University of Texas Medical Branch, Galveston Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2016 Category: Research Source Type: clinical trials

A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)
Condition:   Acute Intermittent PorphyriaInterventions:   Drug: ALN-AS1;   Drug: Sterile Normal Saline (0.9% NaCl)Sponsor:   Alnylam PharmaceuticalsRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 19, 2015 Category: Research Source Type: clinical trials

EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Condition:   Acute Hepatic PorphyriaIntervention:   Sponsor:   Alnylam PharmaceuticalsRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2014 Category: Research Source Type: clinical trials

EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Condition:   Acute Hepatic PorphyriaIntervention:   Sponsor:   Alnylam PharmaceuticalsRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2014 Category: Research Source Type: clinical trials